Adenovirus-mediated gene transfer of dominant negative Ha-Ras inhibits proliferation of primary meningioma cells

Neurosurgery

Volumn 44, Issue 3, 1999, Pages 579-588

  Shu, Junyan ^a   Lee Joung, H ^b   Harwalkar, Jyoti A ^a   Oh Siskovic, Susan ^b   Stacey, Dennis W ^b   Golubic, Mladen ^b  

^a Department of Molecular Biology ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adenovirus; MAP kinase; Meningioma; Proliferation; Ras; Tumorigenesis

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; TYROSINE KINASE RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; ENZYME PHOSPHORYLATION; GENE TRANSFER; HUMAN; HUMAN TISSUE; MENINGIOMA; MITOSIS INHIBITION; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RECOMBINANT;

EID: 0032981034     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199903000-00080     Document Type: Article

References (33)

1. Beckcr TC, Noel R, Coats WS, Gomez-Foix AM, Alam T, Gérard RD, Newgard CB: Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43:161-189, 1994.
2. Carroll RS, Black PM, Zhang J, Kirsch M, Percée I, Lau N, Guha A: Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 87:315-323,1997.
3. Denhardt DT: Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cells: The potential for multiplex signaling. Biochcm J 318:729-747,1996.
4. Deprez LRH, Riegman PHJ, Groen NA, Warringa UL, van Biezen NA, Molijn AC, Bootsma D, de Jong PJ, Menon AG, Kley NA, Scizinger BR, Zwarthoff EC: Cloning and characterization of MN1, a gene from chromosome 22qll, which is disrupted by a balanced translocation in a meningioma. Oncogene 10:1521-1528, 1995.
5. Delta A, Kenny BG, Smith C, Logan A, Hitchcock E: Correlation of proto-oncogene expression and proliferation in meningiomas. Neurosurgery 33:1065-1074, 1993.
6. Figarella-Branger D, Roche PH, Daniel L, Dufour H, Bianco N, Pellissier JF: Cell-adhesion molecules in human meningiomas: Correlation with clinical and morphological data. Neuropathol Appl Neurobiol 23:113-122, 1997.
7. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A: Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15:2755-2765, 1997.
8. Gutmann DH, Giordano MJ, Fishback AS, Guha A: Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 49:267-270, 1997.
9. Hitotsumatsu T, hvaki T, Kitamoto T, Mizoguchi M, Suzuki SO, Hamada Y, Fukui M, Tateishi J: Expression of neurofibromatosis 2 protein in human brain tumors: An immunohistochemical study. Acta Neuropathol (Berl) 93:225-232, 1997.
10. Huynh DP, Mautner V, Baser ME, Stavrou D, Pulst SM: Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. J Neuropathol Exp Neurol 56:382-390,1997.
11. Kazumoto K, Tamura M, Hoshino M, Yuasa Y: Enhanced expression of the sis and c-inyc oncogenes in human meningiomas. J Neurosurg 72:786-791, 1990.
12. Kerkhoff E, Houben R, Lpeffler S, Troppmair J, Lee J-E, Rapp UR: Regulation of c-myc expression by Ras/Raf signaling. Oncogene 16:211-216, 1998.
13. Kohl NE, Wilson FR, Mosser SD, Giuliani E, DeSolms SJ, Conner MW, Anthony NJ, Holts WJ, Gomez RP, Lee T, Smith RL, Graham SL, Hartman GD, Gibbs ]B,.OIiff A: Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc Natl Acad Sci U S A 91:9141-9145, 1994.
14. Kujas M: Meningioma. CUIT Opin Neurol Neurosurg 6:882-887, 1993.
15. Lee JH, Sundaram V, Stein DJ, Kinney SA, Stacey D, Golubic M: Reduced expression of schwannomin/merlin in human sporadic meningiomas. Neurosurgery 40:578-587, 1997.
16. Leevers SJ, Peterson HF, Marshall CJ: Requirement for ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369:411-414, 1994.
17. Lowy DR, Willumsen BM: Function and regulation of ras. Annu Rev Biochem 62:851-691, 1993.
18. Lutchman M, Rouleau GA: Neurofibromatosis Type 2: A new mechanism of tumor suppression. Trends Neurosci 19:373-377,1996.
19. Marais R, Light Y, Mason C, Paterson H, Oison MF, Marshall CJ: Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280:109-112, 1998.
20. Moodie SA, Wolfman A: The 3 Rs of life: Ras, Raf and growth regulation. Trends Genet 10:44-48, 1994.
21. Murphy M, Pyekett MJ, Harnish P, Zang KD, George DL: Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 4:725-722, 1993.
22. Peyrard M, Fransson I, Xie Y-G, Han F-Y, Ruttledge MH, Swahn S, Collins JE, Dunham I, Collins VP, Dumanski JP: Characterization of a new member of the human β-adaptin gene family from chromosome 22ql2, a candidate meningioma gene. Hum Mol Genet 3:1393-1399, 1994.
23. Rüssel DS, Rubinstein LJ: Tumours of the méninges and related tissues, in Pathology of Tumours of the Nenvus System. Baltimore, Williams & Wilkins, 1989, pp 449-532.
24. Schweighoffer F, Cai H, Chevallier-Multon C, Path I, Cooper G, Tocque B: The Saccharomyces cervisiae SDC25 C-domain gene product overcomes the dominant inhibitory activity of Ha-Ras Asn-17. Mol Cel Biol 13:39-43, 1993.
25. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 9:726735, 1995.
26. Shamah SM, Alberta JA, Giannobile WV, Cuba A, Kwon YK, Carroll RS, Black PM, Stiles CD: Detection of activated plateletderived growth factor receptors in human meningiomas. Cancer Res 57:4141-4147, 1997.
27. Stacey DW, Feig LA, Gibbs JB: Dominant inhibitory Ras mutants inhibit the activity of either cellular or oncogenic Ras. Mol Cell Biol 11:4053-4064,1991.
28. Stacey DW, Tsai MH, Yu CL, Smith JK: Critical role of cellular Ras proteins in proliferative signal transduction. Cold Spring Harb Symp Quant Biol LIII:871-881,1988.
29. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF: Activation of Raf as a result of recruitment to the plasma membrane. Science 264:1463-1466,1994.
30. Sundaram V, Lee J, Harwalker JA, Stein DJ, Roudebush M, Stacey DW, Golubic M: Reduced expression of neurofibromin in human meningiomas. Br J Cancer 76:747-756, 1997.
31. Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H: An anti-Ras function of neurofibromatosis Type 2 gene product (NF2/merlin). J Biol Chem 269:23387-23390, 1994.
32. Todo T, Adams EF, Fahlbush R, Dingermann T, Werner H: Autocrine growth Stimulation of human meningioma cells by platelet-derived growth factor. J Neurosurg 84:852-859, 1996.
33. Xu G, Lin B, Tanaka K, Dünn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F: The catalytic domain of the neurofibromatosis Type 1 gene product stimulates rns GTPase and complements ira mutants of S. cerevisiae. Cell 63:835-841, 1990.